Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 EUR | -6.71% | -7.33% | -14.85% |
Mar. 28 | Mister Spex SE Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Transcript : Mister Spex SE, 2023 Earnings Call, Mar 27, 2024 |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The stock, which is currently worth 2024 to 0.01 times its sales, is clearly overvalued in comparison with peers.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.85% | 104M | - | ||
-3.37% | 4.25B | B- | ||
-14.48% | 1.41B | C | ||
-30.64% | 498M | - | ||
-20.22% | 381M | - | ||
+23.06% | 192M | - | - | |
-21.01% | 135M | - | - | |
-7.37% | 133M | - | ||
+0.33% | 92.65M | - | - | |
+4.93% | 72.62M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MRX Stock
- MRX Stock
- Ratings Mister Spex SE